Vincerx Pharma, Inc.
Market Cap
$68.05K
P/E Ratio
—
EPS
$-5.79
Dividend Yield
0.00%
52-Week Range
$0.00 — $1.43
Volume
200
Avg Volume
5.08K
Beta
1.55
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
0.06
P/B (TTM)
0.03
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-4.50%
ROA (TTM)
-4.45%
ROIC
—
Gross Margin
0.50%
Operating Margin
-18.68%
Net Margin
—
Debt/Equity
0.00
Current Ratio
1.79
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.07%
EPS Growth (5Y)
-74.03%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-11.40
EPS Est (Next Year)
$-11.20
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.85
Price Target Range
Consensus Target: $3.00(22976.9% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
5.23M
Float
4.67M
Free Float %
89.14%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2020-05-27
Employees
12
CEO
Raquel E. Izumi
Index Membership
—
Website
https://vincerx.com
Vincerx Pharma, Inc. (VINC) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $68.05K, VINC is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare VINC against other stocks using dozens of fundamental and technical filters.
No, Vincerx Pharma, Inc. (VINC) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Vincerx Pharma, Inc. (VINC) has a market capitalization of $68,046, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.